. 2023 Apr 5;95:106396. doi: 10.1016/j.ultsonch.2023.106396

Table 4.

Antioxidant properties of T-OVA-EGCG and U-OVA-EGCG conjugates.

Samples	DPPH scavenging capacity/%	ABTS scavenging capacity/%
OVA	23.16 ± 2.90^e	17.16 ± 2.18^e
T-OVA-EGCG	68.15 ± 1.35^c	61.02 ± 1.83^c
U-OVA-EGCG30	46.34 ± 3.0^d	30.08 ± 2.60^d
U-OVA-EGCG60	68.61 ± 2.75^c	60.51 ± 1.61^c
U-OVA-EGCG90	89.50 ± 3.31^a	78.01 ± 0.90^a
U-OVA-EGCG120	75.38 ± 1.46^b	70.92 ± 1.83^b

Note: Dates are given as means ± standard deviations. Values with superscript letters in the same column indicate significantly different at P < 0.05. T-OVA-EGCG: ovalbumin-epigallocatechin-3-gallate conjugates prepared by traditional free radical treatment; U-OVA-EGCG30, U-OVA-EGCG60, U-OVA-EGCG90, and U-OVA-EGCG120: the ultrasound-assisted free radical of OVA-EGCG conjugates prepared under different ultrasonic response times of 30 min, 60 min, 90 min, and 120 min, respectively.